Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins and Lifestyle (VITAL) cohort

Gynecologic Oncology

Volumn 128, Issue 1, 2013, Pages 113-119

  Brasky, Theodore M ^a,b   Moysich, Kirsten B ^c   Cohn, David E ^a   White, Emily ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b USA   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Aspirin; Endometrial cancer; Ibuprofen; Naproxen; NSAID

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FOLLOW UP; HAZARD RATIO; HISTOLOGY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCTION; SMOKING; UNITED STATES;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHEMOPREVENTION; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK;

EID: 84871924774     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.10.005     Document Type: Article

References (43)

1. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
2. A.E. Wallace, D.A. Gibson, P.T. Saunders, and H.N. Jabbour Inflammatory events in endometrial adenocarcinoma J Endocrinol 206 2010 141 157
3. L. Dossus, S. Becker, S. Rinaldi, A. Lukanova, A. Tjonneland, and A. Olsen Tumor necrosis factor (TNF)-alpha, soluble TNF receptors and endometrial cancer risk: the EPIC study Int J Cancer 129 8 2011 2032 2037
4. L. Dossus, S. Rinaldi, S. Becker, A. Lukanova, A. Tjonneland, and A. Olsen Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study Endocr Relat Cancer 17 2010 1007 1019
5. T. Wang, T.E. Rohan, M.J. Gunter, X. Xue, J. Wactawski-Wende, and S.N. Rajpathak A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers Cancer Epidemiol Biomarkers Prev 20 2011 971 977
6. G. Kilic, B. Gurates, J. Garon, H. Kang, B. Arun, and C.E. Lampley Expression of cyclooxygenase-2 in endometrial adenocarcinoma Eur J Gynaecol Oncol 26 2005 271 274
7. S.H. Keser, A.E. Gul, N.O. Barisik, C. Cakir, S. Sensu, and N.O. Kandemir The relationship of COX-2 expression with estrogen receptor, progesterone receptor and prognostic parameters in endometrial carcinomas J Obstet Gynaecol Res 36 2010 560 566
8. J.M. Fowler, N. Ramirez, D.E. Cohn, N. Kelbick, J. Pavelka, and I. Ben-Shachar Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis Am J Obstet Gynecol 192 2005 1262 1271 [discussion 1271-3]
9. A.D. Ebert, J. Bartley, and M. David Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions-old answers? Eur J Obstet Gynecol Reprod Biol 122 2005 144 150
10. M.A. Gates, S.S. Tworoger, A.H. Eliassen, S.A. Missmer, and S.E. Hankinson Analgesic use and sex steroid hormone concentrations in postmenopausal women Cancer Epidemiol Biomarkers Prev 19 2010 1033 1041
11. N.E. Allen, T.J. Key, L. Dossus, S. Rinaldi, A. Cust, and A. Lukanova Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr Relat Cancer 15 2008 485 497
12. B.E. Henderson, R.K. Ross, M.C. Pike, and J.T. Casagrande Endogenous hormones as a major factor in human cancer Cancer Res 42 1982 3232 3239
13. K.B. Moysich, J.A. Baker, K.J. Rodabaugh, and J.A. Villella Regular analgesic use and risk of endometrial cancer Cancer Epidemiol Biomarkers Prev 14 2005 2923 2928
14. J. Fortuny, C. Sima, S. Bayuga, H. Wilcox, K. Pulick, and S. Faulkner Risk of endometrial cancer in relation to medical conditions and medication use Cancer Epidemiol Biomarkers Prev 18 2009 1448 1456
15. A.N. Viswanathan, D. Feskanich, E.S. Schernhammer, and S.E. Hankinson Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer Cancer Res 68 2008 2507 2513
16. A.S. Neill, C.M. Nagle, M.M. Protani, A. Obermair, A.B. Spurdle, and P.M. Webb Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis Int J Cancer 2012 [Epub ahead of print. Published online on July 9, 2012. PMID: 22777678]
17. C. Bodelon, J.A. Doherty, C. Chen, M.A. Rossing, and N.S. Weiss Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer Am J Epidemiol 170 2009 1512 1517
18. C. Bosetti, F. Bravi, R. Talamini, M. Montella, E. Negri, and C. La Vecchia Aspirin and risk of endometrial cancer: a case-control study from Italy Eur J Cancer Prev 19 2010 401 403
19. K.N. Danforth, G.L. Gierach, L.A. Brinton, A.R. Hollenbeck, H.A. Katki, and M.F. Leitzmann Nonsteroidal anti-inflammatory drug use and endometrial cancer risk in the NIH-AARP Diet and Health Study Cancer Prev Res (Phila) 2 2009 466 472
20. A.E. Prizment, A.R. Folsom, and K.E. Anderson Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study Cancer Epidemiol Biomarkers Prev 19 2010 435 442
21. V.W. Setiawan, R.K. Matsuno, G. Lurie, L.R. Wilkens, M.E. Carney, and B.E. Henderson Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the multiethnic cohort Cancer Epidemiol Biomarkers Prev 2012
22. A.I. Phipps, G.L. Anderson, B.B. Cochrane, C.I. Li, J. Wactawski-Wende, and G.Y. Ho Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer Horm Cancer 2012 [Epub ahead of print. Published online July 24, 2012. PMID: 22826191]
23. N.R. Cook, I.M. Lee, J.M. Gaziano, D. Gordon, P.M. Ridker, and J.E. Manson Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial JAMA 294 2005 47 55
24. P.M. Rothwell, J.F. Price, F.G. Fowkes, A. Zanchetti, M.C. Roncaglioni, and G. Tognoni Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials Lancet 379 2012 1602 1612
25. M. Bianchi Are all NSAIDs other than 'coxibs' really equal? Trends Pharmacol Sci 25 2004 6 7
26. E. White, R.E. Patterson, A.R. Kristal, M. Thornquist, I. King, and A.L. Shattuck VITamins And Lifestyle cohort study: study design and characteristics of supplement users Am J Epidemiol 159 2004 83 93
27. T. Grosser, E. Smyth, and G. FitzGerald Anti-inflammatory, antipyretic, and analgesic agents; pharmacotherapy of gout L. Brunton, Goodman and Gilman's the pharmacological basis of therapeutics, 12th edition 12th edition ed. 2011 McGraw Hill New York 960 1004
28. R.W. Field, B.J. Smith, C.E. Platz, R.A. Robinson, J.S. Neuberger, and C.P. Brus Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review J Natl Cancer Inst 96 2004 1105 1107
29. A. Imhof, M. Froehlich, H. Brenner, H. Boeing, M.B. Pepys, and W. Koenig Effect of alcohol consumption on systemic markers of inflammation Lancet 357 2001 763 767
30. A.D. Pradhan, J.E. Manson, J.E. Rossouw, D.S. Siscovick, C.P. Mouton, and N. Rifai Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study JAMA 288 2002 980 987
31. B.L. Pierce, M.L. Neuhouser, M.H. Wener, L. Bernstein, R.N. Baumgartner, and R. Ballard-Barbash Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors Breast Cancer Res Treat 114 2009 155 167
32. H.L. Steed, and Q.S. Chu Aromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers? Expert Opin Investig Drugs 20 2011 681 690
33. T.M. Brasky, J.D. Potter, A.R. Kristal, R.E. Patterson, U. Peters, and M.M. Asgari Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort Cancer Causes Control 23 2012 431 444
34. R.W. Brueggemeier, E.S. Diaz-Cruz, P.-K. Li, Y. Sugimoto, Y.C. Lin, and C.L. Shapiro Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer J Steroid Biochem Mol Biol 95 2005 129 136
35. T. Daikoku, Y. Hirota, S. Tranguch, A.R. Joshi, F.J. DeMayo, and J.P. Lydon Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice Cancer Res 68 2008 5619 5627
36. A. Burke, and E. Smyth Analgesic-antipyretic agents; pharmacotherapy of gout L.L. Brunton, J.S. Lazlo, K.L. Parker, Goodman & Gilman's the pharmacological basis of therapeutics 11th ed. 2006 McGraw-Hill New York 671 716
37. C.J. Gallagher, R.M. Balliet, D. Sun, G. Chen, and P. Lazarus Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity Drug Metab Dispos 38 2010 2204 2209
38. C.J. Gallagher, J.E. Muscat, A.N. Hicks, Y. Zheng, A.M. Dyer, and G.A. Chase The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol glucuronidation phenotype and risk for lung cancer Cancer Epidemiol Biomarkers Prev 16 2007 823 828
39. S. Mollerup, G. Berge, R. Baera, V. Skaug, A. Hewer, and D.H. Phillips Sex differences in risk of lung cancer: expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts Int J Cancer 119 2006 741 744
40. B.F. Cole, R.F. Logan, S. Halabi, R. Benamouzig, R.S. Sandler, and M.J. Grainge Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials J Natl Cancer Inst 101 2009 256 266
41. P.M. Rothwell, M. Wilson, C.E. Elwin, B. Norrving, A. Algra, and C.P. Warlow Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Lancet 376 2010 1741 1750
42. P.M. Rothwell, F.G. Fowkes, J.F. Belch, H. Ogawa, C.P. Warlow, and T.W. Meade Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials Lancet 377 2011 31 41
43. B.R.-M.C. Takkouche, and M. Etminan Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis J Natl Cancer Inst 100 2008 1420 1423